G. A. Plisko
G. A. Plisko has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Dmitriy Yur'Evich Ivkin
Center of Experimental Pharmacology, St. Petersburg State Chemical Pharmaceutical University, 14 Prof. Popov Str., 197022 Saint-Petersburg, Russia
6 shared publications - E. D. Semivelichenko
Saint-Petersburg State Chemical and Pharmaceutical University
4 shared publications - Elena Flisyuk
Department of Pharmaceutical Formulations, St. Petersburg State Chemical Pharmaceutical University, 14a Prof. Popov Str., 197022 Saint-Petersburg, Russia
2 shared publications - Irina A. Titovich
Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)
2 shared publications - Kirill O. Sidorov
Saint-Petersburg State Chemical and Pharmaceutical University
2 shared publications - Natalia V. Demakova
Faculty of Pharmacy, Saint Petersburg State Chemical Pharmaceutical University, 14, Prof. Popov Str., 197376 Saint-Petersburg, Russia
2 shared publications
Latest Publications
- Open Access
- 3 December 2025
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 14 (4) , 261-269
Efficacy of ethylmethylhydroxypyridine succinate derivative in a model of intermittent hypoxia in comparison with the reference drug
Introduction. Intermittent hypoxia (IH) promotes oxygen free radical oxidation, which may precede many diseases. Decreased physical activity, ischaemic processes in organs and disturbances at the cellular level, may be a consequence of intermittent hypoxia. It is important to search for potential drugs to correct this process. Aim. Comparative study of the efficacy of the active metabolite of ethylmethylhydroxypyridine succinate (EMHPS), ethylmethylsulfapyridine (EMSP), with a native molecule in a model of IG in mice. Materials and methods. Test subjects were administered intraperitoneally for 14 days – EMSP was administered at a dose of 85 mg/kg, Mexidol® – at a dose of 100 mg/kg. Prolonged intermittent hypoxia was reproduced by placing animals in a membrane hypoxifier. The following conditions have been set for 14 days: 6 % – oxygen content in the hypoxic chamber, duration – 6 hours. The effect of the drug on dynamic load (grip strength test), respiratory parameters (plethysmograph parameters), behavioral and cognitive parameters (open field and elevated plus maze tests), heart rate and venous oxygen saturation were evaluated, and the potential mechanism of action was studied by real-time PCR. Results and discussion. It was found that EMSP was effective in terms of plethysmography parameters, in particular, it helped the body adapt to chronic hypoxic effects, which resulted in significant differences in inhalation and exhalation parameters from the control group. The study of behavioral and cognitive states revealed the presence of anxiety, decreased exploratory activity and increased mobility of animals in all groups. These parameters were less pronounced for animals treated with EMSP and Mexidol® than in the control group. There was a tendency to increase the expression of a gene affecting the ubiquinol-cytochrome c-reductase complex, which is a part of mitochondrial respiration. Conclusion. According to the results of the study, EMSP showed comparable protective properties with a native molecule EMHPS. There was also a tendency to increase the stimulation of UQCRC2 gene against the background of EMSP administration compared with EMHPS.
- 3 December 2025
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 14 (4) , 261-269
Open AccessEfficacy of ethylmethylhydroxypyridine succinate derivative in a model of intermittent hypoxia in comparison with the reference drug
Introduction. Intermittent hypoxia (IH) promotes oxygen free radical oxidation, which may precede many diseases. Decreased physical activity, ischaemic processes in organs and disturbances at the cellular level, may be a consequence of intermittent hypoxia. It is important to search for potential drugs to correct this process. Aim. Comparative study of the efficacy of the active metabolite of ethylmethylhydroxypyridine succinate (EMHPS), ethylmethylsulfapyridine (EMSP), with a native molecule in a model of IG in mice. Materials and methods. Test subjects were administered intraperitoneally for 14 days – EMSP was administered at a dose of 85 mg/kg, Mexidol® – at a dose of 100 mg/kg. Prolonged intermittent hypoxia was reproduced by placing animals in a membrane hypoxifier. The following conditions have been set for 14 days: 6 % – oxygen content in the hypoxic chamber, duration – 6 hours. The effect of the drug on dynamic load (grip strength test), respiratory parameters (plethysmograph parameters), behavioral and cognitive parameters (open field and elevated plus maze tests), heart rate and venous oxygen saturation were evaluated, and the potential mechanism of action was studied by real-time PCR. Results and discussion. It was found that EMSP was effective in terms of plethysmography parameters, in particular, it helped the body adapt to chronic hypoxic effects, which resulted in significant differences in inhalation and exhalation parameters from the control group. The study of behavioral and cognitive states revealed the presence of anxiety, decreased exploratory activity and increased mobility of animals in all groups. These parameters were less pronounced for animals treated with EMSP and Mexidol® than in the control group. There was a tendency to increase the expression of a gene affecting the ubiquinol-cytochrome c-reductase complex, which is a part of mitochondrial respiration. Conclusion. According to the results of the study, EMSP showed comparable protective properties with a native molecule EMHPS. There was also a tendency to increase the stimulation of UQCRC2 gene against the background of EMSP administration compared with EMHPS.
- 29 August 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (8) , 85-95
Comparative study of the neuroprotective effects of the drug Cytoflavin and citicoline in a rats model of hemorrhagic stroke
Objective. To compare the neuroprotective effects of Cytoflavine (CF) and citicoline (CC) in a rat model of hemorrhagic stroke (HS). Material and methods. The study was conducted on male Wistar rats. HS was induced by the injecting of autologous blood into brain tissue. Drugs CF and CC were administered in parenteral (10 days) and oral (25 days) forms. The experiment concluded with a 14-day post-treatment period. Neurological deficits were assessed after each treatment period, and brain tissue edema was measured immediately after the completion of both parenteral and oral treatments and again after 14 days of drug discontinuation. A series limited to a 10-day intravenous treatment with CF was created to compare the efficacy of single and combined treatment regimens. Results. HS stroke led to the development of significant neurological deficits. The greatest improvement was observed in the groups receiving oral treatments with CF and CC, which demonstrated pronounced neuroprotective effects and accelerated recovery of impaired functions, with some differences between the groups. The 10-day intravenous administration of CF and CC resulted in a comparable significant reduction in the severity of neurological deficits related to sensorimotor dysfunction. However, substantial recovery of cognitive function required continuation of oral treatment for 25 days. At the end of the oral treatment phase, edema severity in the affected hemisphere was comparable between both groups and significantly lower than in the placebo group. The therapeutic effect of CF (in terms of neurological deficit and brain tissue edema), in a combined administration regimen, persisted 14 days after discontinuation of treatment, in contrast to CC. In an additional series, where CF treatment was limited to a 10-day intravenous course, the anti-edema effect did not remain significant after the 14-day treatment cessation, with notable differences from the untreated group observed only in motor activity levels. Conclusion. The comparative study of the neuroprotective effects of CF and CC in a rat model of HS revealed that both drugs significantly reduced brain edema and neurological deficits related to sensorimotor and cognitive impairments. CC showed a slight psychostimulatory effect and a shorter duration of action after treatment cessation, while CF exhibited a longer-lasting effect on brain tissue edema, cognitive, and sensorimotor functions after discontinuation. The separate series with only 10-day intravenous CF administration was insufficient to achieve a stable therapeutic effect, suggesting that the continuation of CF treatment with oral forms is required to maintain long-term benefits in the context of experimental HS in rats.
- 29 August 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (8) , 85-95
Comparative study of the neuroprotective effects of the drug Cytoflavin and citicoline in a rats model of hemorrhagic stroke
Objective. To compare the neuroprotective effects of Cytoflavine (CF) and citicoline (CC) in a rat model of hemorrhagic stroke (HS). Material and methods. The study was conducted on male Wistar rats. HS was induced by the injecting of autologous blood into brain tissue. Drugs CF and CC were administered in parenteral (10 days) and oral (25 days) forms. The experiment concluded with a 14-day post-treatment period. Neurological deficits were assessed after each treatment period, and brain tissue edema was measured immediately after the completion of both parenteral and oral treatments and again after 14 days of drug discontinuation. A series limited to a 10-day intravenous treatment with CF was created to compare the efficacy of single and combined treatment regimens. Results. HS stroke led to the development of significant neurological deficits. The greatest improvement was observed in the groups receiving oral treatments with CF and CC, which demonstrated pronounced neuroprotective effects and accelerated recovery of impaired functions, with some differences between the groups. The 10-day intravenous administration of CF and CC resulted in a comparable significant reduction in the severity of neurological deficits related to sensorimotor dysfunction. However, substantial recovery of cognitive function required continuation of oral treatment for 25 days. At the end of the oral treatment phase, edema severity in the affected hemisphere was comparable between both groups and significantly lower than in the placebo group. The therapeutic effect of CF (in terms of neurological deficit and brain tissue edema), in a combined administration regimen, persisted 14 days after discontinuation of treatment, in contrast to CC. In an additional series, where CF treatment was limited to a 10-day intravenous course, the anti-edema effect did not remain significant after the 14-day treatment cessation, with notable differences from the untreated group observed only in motor activity levels. Conclusion. The comparative study of the neuroprotective effects of CF and CC in a rat model of HS revealed that both drugs significantly reduced brain edema and neurological deficits related to sensorimotor and cognitive impairments. CC showed a slight psychostimulatory effect and a shorter duration of action after treatment cessation, while CF exhibited a longer-lasting effect on brain tissue edema, cognitive, and sensorimotor functions after discontinuation. The separate series with only 10-day intravenous CF administration was insufficient to achieve a stable therapeutic effect, suggesting that the continuation of CF treatment with oral forms is required to maintain long-term benefits in the context of experimental HS in rats.
- Open Access
- 27 November 2022
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 11 (4) , 240-245
Approbation of a Model of Fat Liver Disease Induced by Orotic Acid
Introduction. For the treatment of non-alcoholic fatty liver disease (NAFLD), hepatoprotective drugs are actively used. The existing models of non-alcoholic fatty liver disease used to study the effectiveness of medicinal products are characterized by a long duration of recovery and high mortality of test systems, in connection with which, the actual task is to test the screening model of this pathology. A number of studies have shown the hepatotoxic activity of orotic acid (OK), species-specific for rats, leading to the development of NAFLD.Aim. Approbation of the NAFLD model induced by orotic acid on 2 rodent species (mice and rats), research of the reversibility of pathology under the action of a reference drug (ursodeoxycholic acid – UDCA).Materials and methods. The reseacrh was conducted on outbred male rats weighing 260–265 g (n = 21) and inbred male mice of the C57BL/6 line weighing 16–18 g (n = 30). By randomization, the rats were divided into 3 groups (7 rats each): group 1 – intact animals; group 2 – NAFLD model; group 3 – NAFLD + UDCA model, mice were divided into 2 groups (10 and 20 mice, respectively): group 1 – intact animals; group 2 – NAFLD model. NAFLD was modeled by a high-carbohydrate diet with orotic acid (75 % standard feed, 24 % fructose and 1 % potassium orotate). UDCA was administered after the first control point 1 time a day through a probe in terms of 150 mg/kg. Biochemical and histological examination was carried out.Results and discussion. It was revealed that a high-carbohydrate diet with the addition of 1 % potassium orotate for 4 weeks causes moderate balloon dystrophy, mild hepatitis and an increase in the content of alanine aminotransferase and aspartate aminotransferase in the blood of rats and less significant changes in mice. Low animal mortality was also noted. The use of UDCA on the claimed model causes a decrease in the severity of liver dystrophy and a decrease in the level of liver enzymes in the blood.Conclusion. Based on the conducted experiments, rats turned out to be the optimal test system on the reproduced model, and a high-fat diet with the addition of orotic acid allows screening studies of drugs with hepatotropic activity.
- 27 November 2022
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 11 (4) , 240-245
Open AccessApprobation of a Model of Fat Liver Disease Induced by Orotic Acid
Introduction. For the treatment of non-alcoholic fatty liver disease (NAFLD), hepatoprotective drugs are actively used. The existing models of non-alcoholic fatty liver disease used to study the effectiveness of medicinal products are characterized by a long duration of recovery and high mortality of test systems, in connection with which, the actual task is to test the screening model of this pathology. A number of studies have shown the hepatotoxic activity of orotic acid (OK), species-specific for rats, leading to the development of NAFLD.Aim. Approbation of the NAFLD model induced by orotic acid on 2 rodent species (mice and rats), research of the reversibility of pathology under the action of a reference drug (ursodeoxycholic acid – UDCA).Materials and methods. The reseacrh was conducted on outbred male rats weighing 260–265 g (n = 21) and inbred male mice of the C57BL/6 line weighing 16–18 g (n = 30). By randomization, the rats were divided into 3 groups (7 rats each): group 1 – intact animals; group 2 – NAFLD model; group 3 – NAFLD + UDCA model, mice were divided into 2 groups (10 and 20 mice, respectively): group 1 – intact animals; group 2 – NAFLD model. NAFLD was modeled by a high-carbohydrate diet with orotic acid (75 % standard feed, 24 % fructose and 1 % potassium orotate). UDCA was administered after the first control point 1 time a day through a probe in terms of 150 mg/kg. Biochemical and histological examination was carried out.Results and discussion. It was revealed that a high-carbohydrate diet with the addition of 1 % potassium orotate for 4 weeks causes moderate balloon dystrophy, mild hepatitis and an increase in the content of alanine aminotransferase and aspartate aminotransferase in the blood of rats and less significant changes in mice. Low animal mortality was also noted. The use of UDCA on the claimed model causes a decrease in the severity of liver dystrophy and a decrease in the level of liver enzymes in the blood.Conclusion. Based on the conducted experiments, rats turned out to be the optimal test system on the reproduced model, and a high-fat diet with the addition of orotic acid allows screening studies of drugs with hepatotropic activity.
- Open Access
- 1 September 2022
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 11 (3) , 209-219
Study of the Effectiveness of Drugs Based on Molecular Complexes of Adenosine-polymer on the Model of Thermal Burn
Introduction. In modern pharmacology, more and more widely used molecular complexes (MC) based on donor-acceptor or, on weaker, intermolecular interactions, to stabilize dosage forms in the composition of pharmaceutical substances or their targeted delivery. This trend is actively developing, because the molecules forming MK, which has a certain composition and spatial structure, are preserved and can be released unchanged. The use of MC in tandem with "classical" metal-containing coordination compounds, which enhance or modify the action of the active component, allows the development of new, more effective drugs with optimized bioavailability and activity.Aim. Evaluation of the wound-healing effect of new substances based on aqueous systems containing coordination compounds of copper(II) or zinc with MC adenosine-copolymer of N-vinylpyrrolidone, in comparison with the drug Depantol® on a model of thermal burn in mice.Materials and methods. Mononuclear alainate complexes Cu(Ala)2 · H2O and Zn(Ala)2 (Ala – alainate-anion), copolymer of N-vinylpyrrolidone with crotonic acid (PVP-CA) have been synthesized. The composition of the obtained compounds was confirmed by the data of elemental analysis on a CHN (S) analyzer LECO CHNS (O) 932 (Elemental Microanalysis Ltd, Great Britain). IR spectra of the samples were recorded on a IRAffinity-1 (Shimadzu, Japan) instrument (by tabletting a sample with KBr) and a IRTracer-100 (Shimadzu, Japan) instrument equipped with a Specac Quest ATR attachment (Shimadzu Corporation, Japan). Potentiometric titration of the functional groups of the VP copolymer was performed using a PP-20 pH meter (Sartorius AG, Germany). The solutions of the preparations were prepared by dissolving PVP-KK in polyethylene glycol (PEG-400), followed by the addition of an aqueous dispersion of adenosine (Ad) and the corresponding complex of copper(II) or zinc into the preparation. After modeling a thermal burn of the third degree, the overall mortality in the groups and the dynamics of healing of the injured area were assessed. During the experiment, histological studies of areas of damaged tissue after staining of preparations with hematoxylin and eosin were carried out and a generalized scoring assessment of the characteristics of the burn process was carried out, including an assessment of the width and depth of the formed scar tissue, the severity of inflammatory infiltration and the presence of hemosiderosis in the tissues.Results and discussion. The formation of the MC of the copolymer of N-vinylpyrrolidone with crotonic acid with adenosine made it possible to prepare solutions of preparations containing up to 5 % (wght.) Of the latter. In the obtained samples, the molar ratio of PVP-CA : Ad : M(Ala)2 was 100 : 10 : 1 (M = CuII, Zn), the pH level of the obtained preparations was 7.0–7.1. The resulting funds were applied to the damaged area of the skin in a volume of 0.1 ml/day, each individual, daily for 4 weeks. Introductory substances based on MC PVP-CA : Ad : M(Ala)2 showed a moderate wound healing effect in comparison with the drug Depantol®, based on a water-fat emulsion. Substances that do not contain a metal complex and contain Cu(Ala)2 showed better efficiency in the dynamics of healing a burn injury in comparison with other studied substances, which was combined with a low mortality rate of experimental animals in these groups (3 cases and 2 cases out of 9 individuals, respectively). The reference drug – Depantol®, in turn, showed the best result, probably due to the content in its composition, in addition to dexpanthenol, which is characterized by a wound-healing effect, chlorhexidine antiseptic, and a fatty base, which reduces the dehydration of the injured area.Conclusion. Experimental substances based on aqueous solutions of adenosine-polymer MK showed a moderate wound healing effect comparable to the reference drug, which, however, is of sufficient interest for further study of such compositions, or their modified versions with the addition of antimicrobial components on thermal burn models, in order to creation of new, more effective drugs for the healing of wound surfaces.
- 1 September 2022
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 11 (3) , 209-219
Open AccessStudy of the Effectiveness of Drugs Based on Molecular Complexes of Adenosine-polymer on the Model of Thermal Burn
Introduction. In modern pharmacology, more and more widely used molecular complexes (MC) based on donor-acceptor or, on weaker, intermolecular interactions, to stabilize dosage forms in the composition of pharmaceutical substances or their targeted delivery. This trend is actively developing, because the molecules forming MK, which has a certain composition and spatial structure, are preserved and can be released unchanged. The use of MC in tandem with "classical" metal-containing coordination compounds, which enhance or modify the action of the active component, allows the development of new, more effective drugs with optimized bioavailability and activity.Aim. Evaluation of the wound-healing effect of new substances based on aqueous systems containing coordination compounds of copper(II) or zinc with MC adenosine-copolymer of N-vinylpyrrolidone, in comparison with the drug Depantol® on a model of thermal burn in mice.Materials and methods. Mononuclear alainate complexes Cu(Ala)2 · H2O and Zn(Ala)2 (Ala – alainate-anion), copolymer of N-vinylpyrrolidone with crotonic acid (PVP-CA) have been synthesized. The composition of the obtained compounds was confirmed by the data of elemental analysis on a CHN (S) analyzer LECO CHNS (O) 932 (Elemental Microanalysis Ltd, Great Britain). IR spectra of the samples were recorded on a IRAffinity-1 (Shimadzu, Japan) instrument (by tabletting a sample with KBr) and a IRTracer-100 (Shimadzu, Japan) instrument equipped with a Specac Quest ATR attachment (Shimadzu Corporation, Japan). Potentiometric titration of the functional groups of the VP copolymer was performed using a PP-20 pH meter (Sartorius AG, Germany). The solutions of the preparations were prepared by dissolving PVP-KK in polyethylene glycol (PEG-400), followed by the addition of an aqueous dispersion of adenosine (Ad) and the corresponding complex of copper(II) or zinc into the preparation. After modeling a thermal burn of the third degree, the overall mortality in the groups and the dynamics of healing of the injured area were assessed. During the experiment, histological studies of areas of damaged tissue after staining of preparations with hematoxylin and eosin were carried out and a generalized scoring assessment of the characteristics of the burn process was carried out, including an assessment of the width and depth of the formed scar tissue, the severity of inflammatory infiltration and the presence of hemosiderosis in the tissues.Results and discussion. The formation of the MC of the copolymer of N-vinylpyrrolidone with crotonic acid with adenosine made it possible to prepare solutions of preparations containing up to 5 % (wght.) Of the latter. In the obtained samples, the molar ratio of PVP-CA : Ad : M(Ala)2 was 100 : 10 : 1 (M = CuII, Zn), the pH level of the obtained preparations was 7.0–7.1. The resulting funds were applied to the damaged area of the skin in a volume of 0.1 ml/day, each individual, daily for 4 weeks. Introductory substances based on MC PVP-CA : Ad : M(Ala)2 showed a moderate wound healing effect in comparison with the drug Depantol®, based on a water-fat emulsion. Substances that do not contain a metal complex and contain Cu(Ala)2 showed better efficiency in the dynamics of healing a burn injury in comparison with other studied substances, which was combined with a low mortality rate of experimental animals in these groups (3 cases and 2 cases out of 9 individuals, respectively). The reference drug – Depantol®, in turn, showed the best result, probably due to the content in its composition, in addition to dexpanthenol, which is characterized by a wound-healing effect, chlorhexidine antiseptic, and a fatty base, which reduces the dehydration of the injured area.Conclusion. Experimental substances based on aqueous solutions of adenosine-polymer MK showed a moderate wound healing effect comparable to the reference drug, which, however, is of sufficient interest for further study of such compositions, or their modified versions with the addition of antimicrobial components on thermal burn models, in order to creation of new, more effective drugs for the healing of wound surfaces.
- Open Access
- 25 December 2021
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 10 (4) , 171-178
Comparative efficacy of transdermal forms for alopecia therapy
Introduction. Alopecia is a polyetiological disorder characterized by hair loss and reducing their number per unit area. Baldness causes psychological and social discomfort to patients, in connection with what an important task is to develop formulations that are more effective than the reference agents.Aim. Investigate the possibility of applying the original substance Y in several dosage forms for the treatment of alopecia in comparison with reference drugs: minoxidil and burdock oil.Materials and methods. The research subject was the original substance Y, for which several dosage forms were made: gel, alcohol and oil compositions. The study on the effectiveness and safety of the developed formulations was carried out on 9 groups of male C57BL/6 mice. Depilation with further assessment of the percentage of hair follicles in the growth and resting phases was tested as a pre-clinical model of alopecia. In the study of the mechanism of action of substance Y, chemiluminescent assay was performed compared with natural antioxidant quercetin in the system luminol – 2,2'-azo-bis(2-amidinopropane)dihydrochloride, in potassium-phosphate buffer medium (pH = 7.4). Statistical processing of the results was carried out using two-way ANOVA using GraphPad Prism 8.0.2, USA software at the level of statistical significance of differences p < 0.05 and p < 0.005.Results and discussion. Based on the results of histological analysis and visual changes, it was found that the effectiveness of the topical forms of substance Y decreases in the following order: gel, alcohol form, oil composition. The use of a combination of the gel base with the test substance Y resulted to the appearance of a larger number of hair follicles in the growth phase than when using the reference preparation – 2 % minoxidil solution (the differences are statistically significant). Chemiluminescent assessment of antioxidant activity showed the lack of antioxidant effect in substance Y.Conclusion. The study combines two pharmaceutical profiles: technological and pharmacological. In the course of the experiments, the prospects of the gel form of the original substance Y for topical therapy of alopecia were shown. In the near future, it is planned to study the mechanism of action of substance Y, as well as registration of patent protection for a new drug.
- 25 December 2021
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 10 (4) , 171-178
Open AccessComparative efficacy of transdermal forms for alopecia therapy
Introduction. Alopecia is a polyetiological disorder characterized by hair loss and reducing their number per unit area. Baldness causes psychological and social discomfort to patients, in connection with what an important task is to develop formulations that are more effective than the reference agents.Aim. Investigate the possibility of applying the original substance Y in several dosage forms for the treatment of alopecia in comparison with reference drugs: minoxidil and burdock oil.Materials and methods. The research subject was the original substance Y, for which several dosage forms were made: gel, alcohol and oil compositions. The study on the effectiveness and safety of the developed formulations was carried out on 9 groups of male C57BL/6 mice. Depilation with further assessment of the percentage of hair follicles in the growth and resting phases was tested as a pre-clinical model of alopecia. In the study of the mechanism of action of substance Y, chemiluminescent assay was performed compared with natural antioxidant quercetin in the system luminol – 2,2'-azo-bis(2-amidinopropane)dihydrochloride, in potassium-phosphate buffer medium (pH = 7.4). Statistical processing of the results was carried out using two-way ANOVA using GraphPad Prism 8.0.2, USA software at the level of statistical significance of differences p < 0.05 and p < 0.005.Results and discussion. Based on the results of histological analysis and visual changes, it was found that the effectiveness of the topical forms of substance Y decreases in the following order: gel, alcohol form, oil composition. The use of a combination of the gel base with the test substance Y resulted to the appearance of a larger number of hair follicles in the growth phase than when using the reference preparation – 2 % minoxidil solution (the differences are statistically significant). Chemiluminescent assessment of antioxidant activity showed the lack of antioxidant effect in substance Y.Conclusion. The study combines two pharmaceutical profiles: technological and pharmacological. In the course of the experiments, the prospects of the gel form of the original substance Y for topical therapy of alopecia were shown. In the near future, it is planned to study the mechanism of action of substance Y, as well as registration of patent protection for a new drug.
- Open Access
- 10 June 2021
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 8 (2) , 46-57
Approaches to modeling pulmonary embolism and chronic thromboembolic pulmonary hypertension in rodents and medium-sized laboratory animals
Pulmonary embolism (PE) is the third most common cardiovascular disease. It is still associated with high hospital mortality, as well as with the development of acute and chronic complications. Treatment and prevention of PE and its complications requires high-tech approaches aimed at improving the prognosis of patients. In this regard, experimental studies aimed at studying the pathogenesis, improving diagnostic methods and searching for new pharmacological substances for the prevention and treatment of PE are in demand from the point of view of clinical practice. Considering the current trends in preclinical research, experimental work on rodents — mice, rats, hamsters, as well as on medium-sized laboratory animals (rabbits) is becoming more and more common. The use of these animal species is ethically acceptable and economically viable. The choice of a specific type of animal and a method for modeling PE is primarily determined by the objectives of the study. This article provides an overview of the main approaches to modeling PE, as well as discusses the advantages and disadvantages of each method. Special attention is paid to the modeling of chronic thromboembolic pulmonary hypertension (CTEPH) as one of the most dangerous complications of PE. The work analyzed publications from 1978 to 2020, in which PE was simulated in rodents and medium laboratory animals.
- 10 June 2021
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 8 (2) , 46-57
Open AccessApproaches to modeling pulmonary embolism and chronic thromboembolic pulmonary hypertension in rodents and medium-sized laboratory animals
Pulmonary embolism (PE) is the third most common cardiovascular disease. It is still associated with high hospital mortality, as well as with the development of acute and chronic complications. Treatment and prevention of PE and its complications requires high-tech approaches aimed at improving the prognosis of patients. In this regard, experimental studies aimed at studying the pathogenesis, improving diagnostic methods and searching for new pharmacological substances for the prevention and treatment of PE are in demand from the point of view of clinical practice. Considering the current trends in preclinical research, experimental work on rodents — mice, rats, hamsters, as well as on medium-sized laboratory animals (rabbits) is becoming more and more common. The use of these animal species is ethically acceptable and economically viable. The choice of a specific type of animal and a method for modeling PE is primarily determined by the objectives of the study. This article provides an overview of the main approaches to modeling PE, as well as discusses the advantages and disadvantages of each method. Special attention is paid to the modeling of chronic thromboembolic pulmonary hypertension (CTEPH) as one of the most dangerous complications of PE. The work analyzed publications from 1978 to 2020, in which PE was simulated in rodents and medium laboratory animals.